Market capitalization | $386.18m |
Enterprise Value | $951.58m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 18.13 |
EV/Sales (TTM) EV/Sales | 0.92 |
P/S ratio (TTM) P/S ratio | 0.37 |
P/B ratio (TTM) P/B ratio | 0.68 |
Revenue growth (TTM) Revenue growth | -2.22% |
Revenue (TTM) Revenue | $1.04b |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
6 Analysts have issued a Enhabit forecast:
6 Analysts have issued a Enhabit forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,037 1,037 |
2%
2%
|
|
Gross Profit | 475 475 |
4%
4%
|
|
EBITDA | 70 70 |
24%
24%
|
EBIT (Operating Income) EBIT | 39 39 |
35%
35%
|
Net Profit | -117 -117 |
76%
76%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Head office | United States |
CEO | Barbara Jacobsmeyer |
Employees | 10,800 |
Founded | 2014 |
Website | www.ehab.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.